Personal tools

MCL coexpression mm9:435: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000474!2.89e-37!9;UBERON:0003134!7.84e-31!8;UBERON:0003100!1.95e-30!11;UBERON:0000992!4.57e-21!3;UBERON:0005156!1.26e-20!26;UBERON:0000990!1.26e-20!26;UBERON:0004175!4.07e-19!9;UBERON:0003133!1.27e-17!24;UBERON:0003975!2.87e-13!5;UBERON:0001301!7.57e-10!3;UBERON:0006555!7.57e-10!3;UBERON:0005103!7.57e-10!3;UBERON:0000083!7.57e-10!3;UBERON:0009201!7.57e-10!3;UBERON:0004819!7.57e-10!3;UBERON:0006553!7.57e-10!3;UBERON:0003074!7.57e-10!3;UBERON:0003060!7.57e-10!3;UBERON:0001008!9.51e-09!19;UBERON:0000993!1.84e-08!1;UBERON:0006834!2.54e-08!1;UBERON:0000996!3.50e-08!1;UBERON:0005795!4.82e-08!4;UBERON:0000995!4.82e-08!4;UBERON:0002113!8.18e-08!14;UBERON:0003918!8.18e-08!14;UBERON:0011143!8.18e-08!14;UBERON:0005095!8.18e-08!14;UBERON:0007687!8.18e-08!14;UBERON:0000080!1.33e-07!4;UBERON:0005904!1.33e-07!4;UBERON:0006947!1.33e-07!4;UBERON:0002120!1.33e-07!4;UBERON:0004054!1.33e-07!4;UBERON:0004875!1.33e-07!4;UBERON:0004876!1.33e-07!4;UBERON:0005721!1.33e-07!4;UBERON:0005754!1.33e-07!4;UBERON:0007297!1.33e-07!4
|ontology_enrichment_uberon=UBERON:0000474!2.89e-37!9;UBERON:0003134!7.84e-31!8;UBERON:0003100!1.95e-30!11;UBERON:0000992!4.57e-21!3;UBERON:0005156!1.26e-20!26;UBERON:0000990!1.26e-20!26;UBERON:0004175!4.07e-19!9;UBERON:0003133!1.27e-17!24;UBERON:0003975!2.87e-13!5;UBERON:0001301!7.57e-10!3;UBERON:0006555!7.57e-10!3;UBERON:0005103!7.57e-10!3;UBERON:0000083!7.57e-10!3;UBERON:0009201!7.57e-10!3;UBERON:0004819!7.57e-10!3;UBERON:0006553!7.57e-10!3;UBERON:0003074!7.57e-10!3;UBERON:0003060!7.57e-10!3;UBERON:0001008!9.51e-09!19;UBERON:0000993!1.84e-08!1;UBERON:0006834!2.54e-08!1;UBERON:0000996!3.50e-08!1;UBERON:0005795!4.82e-08!4;UBERON:0000995!4.82e-08!4;UBERON:0002113!8.18e-08!14;UBERON:0003918!8.18e-08!14;UBERON:0011143!8.18e-08!14;UBERON:0005095!8.18e-08!14;UBERON:0007687!8.18e-08!14;UBERON:0000080!1.33e-07!4;UBERON:0005904!1.33e-07!4;UBERON:0006947!1.33e-07!4;UBERON:0002120!1.33e-07!4;UBERON:0004054!1.33e-07!4;UBERON:0004875!1.33e-07!4;UBERON:0004876!1.33e-07!4;UBERON:0005721!1.33e-07!4;UBERON:0005754!1.33e-07!4;UBERON:0007297!1.33e-07!4
|tfbs_overrepresentation_for_novel_motifs=0.175413,0.877169,0.157426,0.205657,0.617852,0.618816,0.286882,0.670577,0.398834,0.0604331,0.252112,0.277243,0.165655,0.296787,0.322172,0,0.46143,0.596872,0.0373086,0.53564,0.823639,0.0970082,0.296055,0.294623,0.489022,0.319311,0.923228,0.232181,0.114379,0.230852,0.630968,0.552579,0.590954,0.518279,0.0978183,0.144175,0.0778621,0.274364,0.510225,0.0536011,0.290922,0.225414,0.182703,0.667769,0.287563,0.197508,0.391673,0.244272,0.0604734,0.37148,0.445973,0.341665,0.681799,0.683824,0.700221,0.302599,0.77262,0.26711,0.302464,0.300938,0.534331,0.349585,0.192373,0.43605,0.311703,1.18928,0.829699,1.16897,0.530087,1.02503,0.144846,0.17272,0.00693324,0.731855,0.0291015,0.263994,1.1987,0.381898,0.518764,0.135947,0.696815,0.476893,0.348372,0.157538,0.623727,0.00706257,0.00137583,0.231141,0.395899,1.32869,0.896685,0.62835,1.38593,0.0914951,0.499944,0.0567726,0.370414,0.56686,0.391893,1.27514,1.43314,0.552324,0.667487,1.13461,0.445567,0.225081,0.498793,0.241171,0.139088,0.134388,0.50853,0.669156,0.424252,0.256145,0.903482,0.288262,0.00200355,0.208431,0.462587,1.41339,0.736964,0.4177,0.858612,0.381122,0.955823,0.522111,0.293459,0.558086,0.828246,1.07003,0.651613,0.200314,0.799981,1.52313,0.92434,0.0320829,1.0242,0.64263,0.876916,1.69384,1.29725,0.834212,0.330794,0.562149,0.439856,0.225756,0.394362,1.65442,2.31845,0.0892035,0.0950247,0.00478823,0.685297,0.0594762,0.313008,0.762455,0.907028,0.340691,0.173692,0.181136,0.886073,0.622933,0.522515,0.168927,0.436947,0.306938,0.266569,0.275979,0.0271993
}}
}}

Revision as of 18:21, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:39252942..39252953,+p5@Fyn
Mm9::chr11:70165531..70165534,-p1@Alox15
Mm9::chr12:80428086..80428118,+p@chr12:80428086..80428118
+
Mm9::chr12:80428226..80428237,+p@chr12:80428226..80428237
+
Mm9::chr14:30823271..30823285,+p@chr14:30823271..30823285
+
Mm9::chr14:70215815..70215841,-p@chr14:70215815..70215841
-
Mm9::chr16:89701685..89701690,-p@chr16:89701685..89701690
-
Mm9::chr19:28635507..28635515,-p@chr19:28635507..28635515
-
Mm9::chr1:194971478..194971490,+p@chr1:194971478..194971490
+
Mm9::chr1:4486594..4486612,-p6@Sox17
Mm9::chr2:49577345..49577376,+p@chr2:49577345..49577376
+
Mm9::chr3:100629375..100629390,+p1@Vtcn1
Mm9::chr3:146212163..146212168,+p@chr3:146212163..146212168
+
Mm9::chr6:117887346..117887361,-p1@Fxyd4
Mm9::chr7:130372393..130372399,+p5@Slc5a11
Mm9::chr7:80383531..80383548,-p@chr7:80383531..80383548
-
Mm9::chr9:122648396..122648402,+p@chr9:122648396..122648402
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
female reproductive system2.89e-379
female reproductive organ7.84e-318
female organism1.95e-3011
female gonad4.57e-213
reproductive structure1.26e-2026
reproductive system1.26e-2026
internal genitalia4.07e-199
reproductive organ1.27e-1724
internal female genitalia2.87e-135
epididymis7.57e-103
excretory tube7.57e-103
mesonephric epithelium7.57e-103
mesonephric tubule7.57e-103
nephric duct7.57e-103
kidney epithelium7.57e-103
renal duct7.57e-103
mesonephric duct7.57e-103
pronephric duct7.57e-103
renal system9.51e-0919
oviduct1.84e-081
uterus or analog2.54e-081
vagina3.50e-081
embryonic uterus4.82e-084
uterus4.82e-084
kidney8.18e-0814
kidney mesenchyme8.18e-0814
upper urinary tract8.18e-0814
kidney rudiment8.18e-0814
kidney field8.18e-0814
mesonephros1.33e-074
duct of male reproductive system1.33e-074
male genital duct1.33e-074
pronephros1.33e-074
internal male genitalia1.33e-074
nephrogenic cord1.33e-074
urogenital ridge1.33e-074
pronephric mesoderm1.33e-074
rostral part of nephrogenic cord1.33e-074
presumptive pronephric mesoderm1.33e-074


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:435&oldid=2561655"